LADENBURG THALMANN FINANCIAL SERVICES INC. - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 58 filers reported holding ONCOCYTE CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q4 2019$1,000
-80.0%
500
-80.0%
0.00%
Q3 2019$5,000
-73.7%
2,500
-66.7%
0.00%
Q2 2019$19,000
+850.0%
7,500
+1400.0%
0.00%
Q1 2019$2,000
+100.0%
5000.0%0.00%
Q4 2018$1,0000.0%5000.0%0.00%
Q3 2018$1,0000.0%5000.0%0.00%
Q2 2018$1,0000.0%5000.0%0.00%
Q1 2018$1,000
-50.0%
5000.0%0.00%
Q4 2017$2,000500
+2281.0%
0.00%
Q3 2016$0210.0%0.00%
Q2 2016$0210.0%0.00%
Q1 2016$0210.00%
Other shareholders
ONCOCYTE CORP shareholders Q4 2019
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 14,716,204$20,456,0001.61%
PURA VIDA INVESTMENTS, LLC 6,022,534$8,371,0000.43%
P.A.W. CAPITAL CORP 199,700$278,0000.30%
Penbrook Management LLC 229,425$319,0000.28%
PERKINS CAPITAL MANAGEMENT INC 39,725$55,0000.05%
GSA CAPITAL PARTNERS LLP 201,047$279,0000.05%
Private Wealth Partners, LLC 150,000$209,0000.02%
Phoenix Holdings Ltd. 317,138$426,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 255,300$355,0000.01%
ETF MANAGERS GROUP, LLC 157,933$226,0000.01%
View complete list of ONCOCYTE CORP shareholders